Intrauterine use of hyperconcentrated platelet concentrates collected with Trima Accel in a case of neonatal alloimmune thrombocytopenia

Transfusion

Volumn 47, Issue 8, 2007, Pages 1488-1493

  Ringwald, Juergen ^a   Schroth, Michael ^a   Faschingbauer, Florian ^a   Strobel, Julian ^a   Strasser, Erwin ^a   Schild, Ralf L ^a   Goecke, Tamme W ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; IMMUNOGLOBULIN G1; THROMBOCYTE ANTIGEN; THROMBOCYTE CONCENTRATE;

ADULT; ARTICLE; CASE REPORT; CESAREAN SECTION; CORDOCENTESIS; FEMALE; FETUS; GENOTYPE; GESTATIONAL AGE; HUMAN; NEWBORN ALLOIMMUNE THROMBOCYTOPENIA; PARENT; PREGNANCY; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADULT; BLOOD COMPONENT REMOVAL; CORDOCENTESIS; FEMALE; HUMANS; INFANT, NEWBORN; ISOANTIGENS; PLATELET TRANSFUSION; THROMBOCYTOPENIA;

EID: 34547122862     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01288.x     Document Type: Article

References (26)

1. Bussel JB, Zacharoulis S, Kramer K, McFarland JG, Pauliny J, Kaplan C. Clinical and diagnostic comparision of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia. Pediatr Blood Cancer 2005 45 : 176 83.
2. Mueller-Eckhardt C, Kiefel V, Grubert A, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989 1 : 363 6.
3. Ouwehand WH, Smith G, Ranasinghe E. Management of severe alloimmunte thrmbocytopenia in the newborn. Arch Dis Child 2000 82 : 173 5.
4. Kaplan C. Alloimmune thrombocytopenia of the fetus and the newborn. Blood Rev 2002 16 : 69 72.
5. Davoren A, Curtis BR, Aster RH, McFarland JG. Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004 44 : 1220 5.
6. Mandelbaum M, Koren D, Eichelberger B, Auerbach L, Panzer S. Frequencies of maternal platelet alloantibodies and autoantibodies in suspected fetal/neonatal isoimmune thrombocytopenia, with emphasis on human platelet antigen-15 alloimmunisation. Vox Sang 2005 89 : 39 43.
7. Berkowitz RL, Bussel JB, McFarland JG. Alloimmune thrombocytopenia: state of the art 2006. Am J Obstet Gynecol 2006 195 : 907 13.
8. Kaplan C, Murphy MF, Kroll H, Waters AH. Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IVIgG and steroids - more questions than answers. European Working Group on FMAIT. Br J Haematol 1998 100 : 62 5.
9. Murphy MF, Waters AH, Doughty HA, et al. Antenatal management of fetomaternal alloimmune thrombocytopenia - report of 15 affected pregnancies. Transfus Med 1994 4 : 281 92.
10. Ringwald J, Althoff F, Zimmermann R, et al. Washing platelets with new additive solutions - aspects on the in vitro quality after 48 hours of storage. Transfusion 2006 46 : 236 43.
11. Allen DJ, Samol J, Benjamin S, Verjee S, Tusold A, Murphy MF. Survey of the use and clinical effectiveness of HPA-1a/5b-negative platelet concentrates in proven or suspected platelet alloimmunization. Transfus Med 2004 14 : 409 17.
12. German Medical Association and Paul Ehrlich Institute. Guidelines for the collection of blood and blood components and the use of blood products (Hemotherapy). Cologne : Deutscher Aerzteverlag 2005.
13. German Society for Transfusion Medicine and Immunohematology. Performance of preparative cellular hemapheresis for the collection of blood cell concentrates. II. Recommendations for preparative white cell and platelet apheresis. Infusionsther Transfusionsmed 1998 25 : 376 82.
14. Guide to the preparation, use and quality assurance of blood components. Strasbourg : Council of Europe Press 2006.
15. Ringwald J, Zingsem J, Zimmermann R, Strasser E, Antoon M, Eckstein R. First comparison of productivity and citrate donor load between the Trima version 4 (dual-stage filler) and the Trima Accel (single-stage filler) in the same donors. Vox Sang 2003 85 : 267 75.
16. Zingsem J, Weisbach V, Zimmermann R, Glaser A, Bunkens H, Eckstein R. Preparation of FFP as a by-product of plateletpheresis. Transfusion 2002 42 : 81 6.
17. Zingsem J, Zimmermann R, Weisbach V, Glaser A, van Waeg G, Eckstein R. Comparison of COBE white cell-reduction and standard plateletpheresis protocols in the same donors. Transfusion 1997 37 : 1045 9.
18. Lutz P, Dzik WH. Large-volume hemocytometer chamber for accurate counting of white cells (WBCs) in WBC-reduced platelets: validation and application for quality control of WBC-reduced platelets prepared by apheresis and filtration. Transfusion 1993 33 : 409 12.
19. Moroff G, Eich J, Dabay M. Validation of use of the Nageotte hemocytometer to count low levels of white cells in white cell-reduced platelet components. Transfusion 1994 34 : 35 8.
20. Davis KB, Slichter SJ, Corash L. Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution. Transfusion 1999 39 : 586 92.
21. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987 317 : 1090 9.
22. Kroll H, Maier HF. [Diseases of fetus and newborn]. In : Mueller-Eckhardt C, Kiefel V, editors. [Transfusion Medicine]. 3rd ed. Berlin : Springer Verlag 2004.
23. Dumont LJ, Krailadsiri P, Seghatchian J, Taylor LA, Howell CA, Murphy MF. Preparation and storage characteristics of white cell-reduced high-concentrations platelet concentrates collected by an apheresis system for transfusions in utero. Transfusion 2000 40 : 91 100.
24. Ringwald J, Duerler T, Frankow O, et al. Collection of hyperconcentrated platelets with Trima Accel. Vox Sang 2006 90 : 92 6.
25. Ringwald J, Haager B, Krex D, et al. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets. Transfusion 2006 46 : 942 8.
26. Gambro BCT platelet storage recommendations. Lakewood (CO) : Gambro BCT, Inc. 2005.